1642 studies found for:    serotonin reuptake inhibitor
Show Display Options
Rank Status Study
1 Terminated 12 Week Safety Trial of Flibanserin in Depressed Women Taking a Selective Serotonin Reuptake Inhibitor or Norepinephrine Serotonin Reuptake Inhibitor With Decreased Sexual Desire and Distress
Conditions: Sexual Dysfunctions, Psychological;   Depression
Interventions: Drug: flibanserin 2;   Drug: placebo;   Drug: flibanserin 1
2 Completed The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
Conditions: Gastric Bypass;   Depression;   Anxiety Disorder
Intervention: Procedure: Roux-en-Y gastric bypass (RYGBP)
3 Completed Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients
Condition: Overactive Bladder
Interventions: Drug: Selective serotonin reuptake inhibitors;   Drug: Antimuscarinics
4 Recruiting A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
Condition: Obsessive-Compulsive Disorder
Interventions: Drug: pregabalin;   Drug: Placebo
5 Completed A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
6 Completed A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: LY2216684;   Drug: Placebo
7 Recruiting Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors
Condition: Tracheostomy Complication
Intervention:
8 Completed Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
Condition: Sexual Dysfunction
Intervention: Drug: Ropinirole (Requip)
9 Completed
Has Results
Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: Placebo;   Drug: 323U66 (Bupropion Hydrochloride Sustained Release)
10 Completed Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression
Condition: Depression
Interventions: Drug: S-adenosyl methione (SAMe);   Drug: Placebo
11 Completed A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
12 Completed Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Quetiapine fumarate (Seroquel)
13 Recruiting Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
Condition: Borderline Personality Disorder
Intervention: Drug: Escitalopram
14 Completed Fluoxetine on Motor Rehabilitation After Ischemic Stroke
Conditions: Ischemic Stroke;   Motor Impairment
Interventions: Drug: fluoxetine;   Drug: placebo
15 Recruiting A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
Condition: Obsessive-Compulsive Disorder
Interventions: Drug: bitopertin;   Drug: placebo
16 Terminated Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
Condition: Obsessive-compulsive Disorder
Interventions: Drug: Ondansetron;   Drug: Placebo
17 Recruiting Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy
Conditions: Patient Diagnosed With OCD;   and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).
Interventions: Drug: AFQ056;   Drug: Placebo
18 Completed
Has Results
MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women
Conditions: Hot Flashes;   Menopause;   Vasomotor Symptoms
Interventions: Drug: Escitalopram;   Other: Placebo
19 Completed Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)
Conditions: Alcoholism;   Alcohol Abuse
Interventions: Drug: Citalopram + MI;   Behavioral: Placebo + MI
20 Terminated Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes
Condition: Depression
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years